Community Health Systems, Inc. (CYH): Price and Financial Metrics
Community Health Systems, Inc. (CYH)
Today's Latest Price: $9.05 USD
Updated Jan 15 7:00pm
Add CYH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 10 in Medical - Hospitals
See all "A" rated Strong Buy stocks
CYH Stock Summary
- Community Health Systems Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 2.22% of US listed stocks.
- CYH's price/sales ratio is 0.08; that's higher than the P/S ratio of just 1.31% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -7.47 for Community Health Systems Inc; that's greater than it is for only 2.34% of US stocks.
- If you're looking for stocks that are quantitatively similar to Community Health Systems Inc, a group of peers worth examining would be GEN, MIK, UIS, STG, and TUP.
- Visit CYH's SEC page to see the company's official filings. To visit the company's web site, go to www.chs.net.
CYH Stock Price Chart Interactive Chart >
CYH Price/Volume Stats
| Current price | $9.05 | 52-week high | $11.04 |
| Prev. close | $8.38 | 52-week low | $2.25 |
| Day low | $8.32 | Volume | 7,485,700 |
| Day high | $9.11 | Avg. volume | 2,590,170 |
| 50-day MA | $8.20 | Dividend yield | N/A |
| 200-day MA | $5.07 | Market Cap | 1.08B |
Community Health Systems, Inc. (CYH) Company Bio
Community Health Systems provides general and specialized hospital healthcare services to patients in the United States. The company was founded in 1985 and is based in Franklin, Tennessee.
CYH Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $9.05 | $365.46 | 3938% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Community Health Systems Inc. To summarize, we found that Community Health Systems Inc ranked in the 95th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 3958% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for CYH, they are:
- 7% of the company's capital comes from equity, which is greater than just 1.83% of stocks in our cash flow based forecasting set.
- The business' balance sheet reveals debt to be 93% of the company's capital (with equity being the remaining amount). Approximately 98.13% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- The weighted average cost of capital for the company is 12. This value is greater than 88.64% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 3859% |
| 1% | 3899% |
| 2% | 3938% |
| 3% | 3978% |
| 4% | 4017% |
| 5% | 4057% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CYH, try MNKKQ, NVCR, RDY, AMEH, and BEAT.
Loading social stream, please wait...